Company Snapshot
Semmelweisstrasse 7
Planegg, 82152
Germany
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 426
Please select from the dropdown
Company Financials

2021
2022
2023
Gross Profit
$147,417,139
$229,647,118
$179,924,278
Operating Income
-$277,623,688
-$220,711,042
-$250,855,861
Net Income
-$514,460,016
-$151,058,190
-$189,734,199
2021
Gross Profit
$147,417,139
Operating Income
-$277,623,688
Net Income
-$514,460,016
2022
Gross Profit
$229,647,118
Operating Income
-$220,711,042
Net Income
-$151,058,190
2023
Gross Profit
$179,924,278
Operating Income
-$250,855,861
Net Income
-$189,734,199
The above data on MorphoSys came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Chaiman of the Supervisory Board
$149,400
$0
$0
$149,400
$149,400
Chaiman of the Supervisory Board
Deputy Chairman of the Supervisory Board
$100,100
$0
$0
$100,100
Deputy Chairman of the Supervisory Board
Member of the Supervisory Board
$89,300
$0
$0
$89,300
Member of the Supervisory Board
MorphoSys listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us